Status:
UNKNOWN
Correlation Between Circulating Galactomannan and Beta-D-glucan and Clinical Outcome of Invasive Aspergillosis
Lead Sponsor:
University Hospital, Gasthuisberg
Conditions:
Invasive Aspergillosis
Eligibility:
All Genders
18-90 years
Brief Summary
The investigators hypothesize that early galactomannan and beta-D-glucan features, namely the height of the initial value at the time of diagnosis and the subsequent rate of marker decay within the fi...
Detailed Description
A major challenge in the development of antifungal therapies for invasive fungal infections is the difficulty in assessing early treatment response and clinical prognosis. Mycological endpoints are of...
Eligibility Criteria
Inclusion
- proven or probable invasive aspergillosis with positive GM antigen test
Exclusion
- Seronegative aspergillosis
Key Trial Info
Start Date :
July 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2011
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01176071
Start Date
July 1 2010
End Date
January 1 2011
Last Update
August 5 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.